Kaspar et al. have reported that IGF-1 overexpression in skeletal muscle increased survival and prevented motor neuron death in an animal model of ALS, although a clinical study using IGF-1 therapy did not demonstrate any improvement [30]. Here, IGF1 is linked to amyotrophic lateral sclerosis.